Rare diseases
Investigational molecules
Locations
Back to Italy920 clinical trials in Treviso, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on the Safety and Tolerability of A3907 for Adults with Primary Sclerosing Cholangitis (PSC)
ItalyItalyStudy on Botensilimab Alone and with Balstilimab or Drug Combination for Patients with Refractory Metastatic Colorectal Cancer
ItalyStudy of Pembrolizumab in Patients with Esophageal Cancer Undergoing Chemoradiotherapy
ItalyStudy Comparing ARV-471 and Fulvestrant for Patients with Advanced Estrogen Receptor-Positive, HER2-Negative Breast Cancer After Endocrine Treatment
ItalyStudy on Nivolumab for Preventing Melanoma Recurrence in Patients with Completely Removed Stage IIB/C Melanoma
ItalyStudy of Capivasertib with CDK4/6 Inhibitors and Fulvestrant for Patients with Advanced HR+/HER2- Breast Cancer
ItalyStudy on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
ItalyContinued Darolutamide Treatment for Cancer Patients from Previous Bayer Studies
ItalyStudy on Long-Term Safety of Eplontersen for Adults with Transthyretin-Mediated Amyloid Cardiomyopathy
ItalyStudy on BIA 28-6156 for Parkinson's Disease in Patients with GBA1 Gene Variant
ItalyLong-Term Follow-Up Study of Imlifidase in Highly Sensitized Kidney Transplant Patients
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials exploring treatments for Acute Myeloid Leukemia and Lymphomas, including studies on targeted therapies combined with standard chemotherapy. Research focuses on improving treatment outcomes for various blood cancers.
Advanced therapeutic approaches aim to enhance minimal residual disease control and patient outcomes.
Comprehensive research into ovarian cancer treatments, including studies of maintenance therapies and novel drug combinations. Investigations focus on both recurrent and newly diagnosed cases.
Studies emphasize personalized treatment approaches based on specific genetic markers and disease characteristics.
Groundbreaking research in lung cancer and severe respiratory conditions, including targeted therapies for specific genetic mutations and innovative treatment combinations.
Focus on developing personalized treatment strategies for various lung cancer subtypes and respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
